HOney versus Nasal Eradication of staphYlococci for the Prevention Of Tenckoff infections in PD

Principal Investigator: Professor David Johnson
Clinical Research Associate: Liza Vergara (AKTN)
Trial Number: AKTN 06.02

Population: Peritoneal Dialysis patients
Final recruitment number: 371 (target of 370)
Intervention: Medihoney applied to exit site twice daily versus standard practice for 24 months
primary outcome: Time to event: exit-site infection, tunnel infection, peritonitis

Results: The HONEYPOT trial showed that topical honey is not more effective than standard practice in the prevention of catheter-associated infections in peritoneal dialysis patients. Results of the study have been published in the Lancet Infectious Diseases and peritoneal Dialysis International.